Society of Interventional Radiology Clinical Practice Guidelines

Cardella, John F.; Kundu, Sanjoy; Miller, Donald L.; Millward, Steven F.; Sacks, David

doi:10.1016/j.jvir.2009.04.035

Cited by 216 publications

(121 citation statements)

References 1 publication

Supporting

Mentioning

119

Contrasting

Order By: Relevance

“…The catheter remained in place. This fits the SIR criteria we were following [13] and was similarly categorized in other papers. In Dewald et al, there was a 0.5% incidence of pneumonia and/or aspiration in a study of 550 patients, characterized as a minor complication [14].…”

Section: Discussionsupporting

confidence: 58%

See 1 more Smart Citation

Percutaneous radiologic gastrostomy catheter placement without gastropexy: a co-axial balloon technique and evaluation of safety and efficacy

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 58%

“…Complications of PRG were classified by the outcome as minor or major according to the Society of Interventional Radiology classification system [13].…”

Section: Techniquementioning

confidence: 99%

Percutaneous radiologic gastrostomy catheter placement without gastropexy: a co-axial balloon technique and evaluation of safety and efficacy

et al. 2016

View full text Add to dashboard Cite

show abstract

“…To avoid leakage of the sclerosant, manual compression was applied at the puncture sites after needle removal. Complications were documented using the Quality Improvement Guidelines for the Reporting and Archiving of Interventional Radiology Procedures [21].…”

Section: Sclerotherapy Of Vascular Malformationsmentioning

confidence: 99%

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

Clemens

Baumann

Husmann

et al. 2017

Vasa

View full text Add to dashboard Cite

Summary:Background: Congenital venous malformations are frequently treated with sclerotherapy. Primary treatment goal is to control the often size-related symptoms. Functional impairment and aesthetical aspects as well as satisfaction have rarely been evaluated. Patients and methods: Medical records of patients who underwent sclerotherapy of spongiform venous malformations were reviewed and included in this retrospective study. The outcome of sclerotherapy as self-reported by patients was assessed in a 21 item questionnaire. Results: Questionnaires were sent to 166 patients with a total of 327 procedures. Seventy-seven patients (48 %) with a total of 159 procedures (50 %) responded to the survey. Fifty-seven percent of patients were male. The age ranged from 1 to 38.1 years with a median age of 16.4 years. The lower extremities were the most common treated area. Limitations caused by the venous malformation improved in the majority of patients (e.g. pain improvement 87 %, improvement of swelling 83 %) but also worsening of symptoms occurred in a minority of cases. Seventy-seven per cent would undergo sclerotherapy again. Conclusions: Sclerotherapy for treatment of venous malformations results in signifi cant reduction of symptoms. Multiple treatments are often needed, but patients are willing to undergo them.

show abstract

“…As per the Society of Interventional Radiology Clinical Practice guidelines, standards for reporting techniques and terminology are used [24]. According to the standardization of terminology and reporting criteria by Brown et al [6], the DEBDOX device does not fit into either as a ''chemoembolization'' (aqueous chemotherapy is not infused) or as an ''embolization'' (because chemotherapy is delivered); thus, we have used the terminology of ''precision chemoembolization'' to define this device at this present time.…”

Section: Image-guided Infusion Techniquementioning

confidence: 99%

Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin

Martin

Robbins

Fagés

et al. 2011

Breast Cancer Res Treat

View full text Add to dashboard Cite

The purpose of this study was to evaluate the efficacy of image-guided delivery of locoregional chemotherapy to breast cancer hepatic metastases using doxorubicin-loaded drug-eluting beads (DEBDOX). An IRB-approved multi-center, prospective, open, non-controlled repeat treatment registry to investigate the safety and efficacy of doxorubicin microspheres in the treatment of patients with unresectable liver metastasis from breast cancer was reviewed. Statistical analysis was performed with differences of P < 0.05 considered significant. About 40 patients with metastatic breast cancer (MBC) to the liver underwent a total of 75 image-guided procedures with hepatic arterial drug-eluting beads loaded with doxorubicin (DEBDOX). Treatment was well tolerated with a total of eight patients sustaining 13 adverse events within the 30 days of each treatment session. All adverse events were either a grade I or grade II in toxicity. After a median follow-up of 12 months in all patients, the hepatic progression-free survival was a median of 26 months and overall survival was a median of 47 months. The treatment of hepatic metastasis from MBC using DEBDOX is an effective local therapy with very high response rates and a very safe toxicity profile. In comparison to chemotherapy alone, consideration of hepatic-directed therapy is warranted in patients with liver-dominant metastatic disease.

show abstract

Society of Interventional Radiology Clinical Practice Guidelines

Cited by 216 publications

References 1 publication

Percutaneous radiologic gastrostomy catheter placement without gastropexy: a co-axial balloon technique and evaluation of safety and efficacy

Percutaneous radiologic gastrostomy catheter placement without gastropexy: a co-axial balloon technique and evaluation of safety and efficacy

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin

Contact Info

Product

Resources

About